Post-traumatic stress disorder in different types of stress (clinical features and treatment)

Neuroscience and Behavioral Physiology

Volumn 38, Issue 1, 2008, Pages 55-61

  Rumyantseva, G M ^a   Stepanov, A L ^a  

^a V P Serbskii State Research Center of Social and Forensic Psychiatry   (Russian Federation)

Author keywords

Clinical features of PTSD; Coaxil (tianeptine); Dependence on type of extreme situation; Post traumatic stress disorder (PTSD); Treatment

Indexed keywords

TIANEPTINE;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CHERNOBYL ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; EXCITABILITY; HUMAN; MAJOR CLINICAL STUDY; POSTTRAUMATIC STRESS DISORDER; SOCIAL ADAPTATION; SOCIAL STATUS; SOLDIER; STRESS; TREATMENT DURATION; WAR; WORKER;

ADULT; ANTIDEPRESSIVE AGENTS; CHERNOBYL NUCLEAR ACCIDENT; COMBAT DISORDERS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MILITARY PERSONNEL; OCCUPATIONAL DISEASES; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; THIAZEPINES; TIME FACTORS;

EID: 37549043107     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-008-0008-0     Document Type: Article

References (15)

1. Yu. A. Aleksandrovskii et al., "Efficacy and tolerance of Coaxil (tianeptine) in the treatment of post-traumatic stress disorder," Zh. Nevrol. Psikhiat., 105, No. 11, 24-29 (2005).
2. Yu. A. Aleksandrovskii, The Problem of Post-Traumatic Stress Disorder and Approaches to Treatment [in Russian], Moscow (2005).
3. V. M. Voloshin, "Treatment of chronic post-traumatic stress disorder with the atypical tricyclic antidepressant tianeptine (Coaxil)," Psikhiat. Psikhofarmakoter., 5, 1 (2003).
4. G. M. Rumyantseva, M. O. Lebedeva, T. M. Levina, et al., Chronic Ecological Stress and Post-Traumatic Stress Disorder in Populations Involved in the Chernobyl Nuclear Power Station Disaster. Old and New Problems in Boundary Psychiatry [in Russian], Moscow (1997), pp. 54-66.
5. N. V. Tarabrina, Handbook in the Psychology of Post-Traumatic Stress [in Russian], Piter, St. Petersburg (2001).
6. J. A. Costa e Silva et al., "Placebo-controlled study of tianeptine in major depressive episodes," Neuropsychobiol., 35, No. 1, 24-29 (1997).
7. L. Davidson and A. Baum, "Chronic stress and posttraumatic stress disorders," J. Consult. Clin. Psychol., 54, No. 3, 303-308 (1986).
8. C. Delbende, D. Bunel, G. Tarozzo, et al., "Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis," Eur. J. Pharmacol., 251, 245-251 (1994).
9. B. L. Green, J. D. Lindy, and M. C. Grace, Psychological Effects of Toxic Contamination. Individual and Community Responses to Trauma and Disaster, Cambridge University Press (1994).
10. M. J. Horowitz, D. S. Weiss, and C. Marmar, "Diagnosis of post-traumatic stress disorder," J. Nerv. Ment. Dis., 175, 276-277 (1987).
11. R. Lazarus and S. Folkman, Stress, Appraisal and Coping, Springer, New York (1984).
12. V. Novotny and F. Faltus, "Tianeptine and fluoxetine in major depression: A 6-week randomised double-blind study/human," Psychopharmacology, 17, No. 6, 299-303 (2002).
13. G. Thomas, "Tianeptine in PTSD: A double-blind study versus placebo. Protocol and methodological issues," in: 11 World Congress of Psychiatry, Hamburg (1999).
14. H. M. Vyner, "The psychological dimension of health care for patients exposed to radiation and the other invisible environmental contaminants," Social Sci. Med., 27, 1097-1103 (1988).
15. L. Waintraub, L. Septien, and P. Azoulay, "Efficacy and safety of tianeptine in major depression: Evidence from a 3-month controlled clinical trial versus paroxetine," CNS Drugs, 16, No. 1, 65-75 (2002).